Cannabis and Pregnancy: Peer-Reviewed Research Consensus
Overview
The research base for cannabis and pregnancy includes 416 peer-reviewed studies spanning 1986–2026. Of these, 49 provide strong evidence, including 9 meta-analyses and 0 randomized controlled trials. Key findings with strong support include: meta-analysis of 57 studies found prenatal cannabis exposure increased risks of preterm birth (68%), low birth weight (160%), and nicu admission (151%), with limited cognitive effects beyond attention problems, and meta-analysis of 36 studies and 18 million births found prenatal cannabis exposure associated with 2-3x higher risks of cardiovascular, gi, cns, and genitourinary birth defects. However, several findings remain debated, and the evidence is not uniform across all areas. Many studies have methodological limitations including small sample sizes, short follow-up periods, and reliance on self-reported data.
What the Research Shows
Findings supported by multiple peer-reviewed studies. Stronger evidence means more consistency across study types.
Meta-analysis of 57 studies found prenatal cannabis exposure increased risks of preterm birth (68%), low birth weight (160%), and NICU admission (151%), with limited cognitive effects beyond attention problems
Strong EvidenceMeta-analysis of 36 studies and 18 million births found prenatal cannabis exposure associated with 2-3x higher risks of cardiovascular, GI, CNS, and genitourinary birth defects
Strong EvidenceMeta-analysis of 14 studies found prenatal cannabis exposure associated with higher ADHD symptom scores and a 30% increased risk of autism, involving over 200,000 participants
Strong EvidenceWhere Scientists Disagree
Areas where research shows conflicting results or ongoing scientific debate.
A major 1986 pharmacological review found cannabis's greatest health concern was its impact on youth development, while finding no proven brain damage and limited physical dependence in adults
Moderate EvidenceIn 131 children followed from birth, prenatal cigarette exposure was linked to lower reading and language scores in a dose-dependent pattern, while prenatal marijuana exposure showed no significant effect
Moderate EvidencePrenatal cigarette exposure reduced birth weight but children caught up quickly
Moderate EvidencefMRI study showing young adults prenatally exposed to marijuana had increased brain activation during impulse control tasks and more errors, with effects persisting after controlling for current drug use
Moderate EvidenceWhat We Still Don't Know
- Only 0 randomized controlled trials exist out of 416 studies — most evidence is observational or from reviews.
- Long-term prospective studies tracking outcomes over 5+ years are largely absent from the literature.
- Research on diverse populations (different ages, ethnicities, and medical backgrounds) remains limited.
Evidence Breakdown
Distribution of study types in this research area. Higher-tier evidence (meta-analyses, RCTs) provides stronger conclusions.
Key Studies
The most impactful research in this area.
Meta-Analysis Links Prenatal Cannabis to Smaller Babies
This meta-analysis pools evidence from multiple studies to provide a clearer picture of prenatal cannabis risks. The significant findings for birth size outcomes add confidence to what individual studies have suggested.
Cannabis Use in Pregnancy Linked to Preterm Birth, Low Birth Weight, and Small Babies Even After Accounting for Tobacco
This is one of the largest and most rigorous analyses of cannabis and pregnancy outcomes. The upgrade from low to moderate certainty evidence, combined with the enormous sample size, substantially strengthens the case that prenatal cannabis use carries real risks to newborns.
Prenatal Cannabis Linked to Preterm Birth, Low Birth Weight, and NICU Stays
This is the most comprehensive meta-analysis to date on prenatal cannabis effects. The birth outcome findings are robust, while the more nuanced cognitive finding (limited to attention/externalizing) pushes back against overly broad claims of developmental harm.
Prenatal Cannabis Linked to Multiple Types of Birth Defects in Large Meta-Analysis
This is the most comprehensive meta-analysis to date linking prenatal cannabis to specific types of structural birth defects. The consistent 2-3x risk increases across multiple organ systems suggests a broad teratogenic effect rather than a system-specific one.
Prenatal Cannabis Exposure Linked to Higher ADHD and Autism Risk in Children
ADHD and ASD are among the most common neurodevelopmental disorders, and identifying modifiable risk factors is a public health priority. This meta-analysis provides pooled evidence that prenatal cannabis exposure may be one such factor.
Meta-analysis found inconsistent evidence linking prenatal cannabis to birth defects, with two specific exceptions
This is the most comprehensive meta-analysis to date on cannabis and birth defects. The finding that most associations disappear after adjustment suggests confounding (tobacco, alcohol, socioeconomic factors) drives much of the apparent risk.
Research Timeline
How our understanding of this topic has evolved.
Pre-2000
4 studies published. Predominantly observational and review studies.
2000–2009
9 studies published. Predominantly observational and review studies.
2010–2014
10 studies published. Includes 1 strong-evidence studies.
2015–2019
47 studies published. Includes 3 strong-evidence studies.
2020–present
346 studies published. Includes 9 meta-analyses, 45 strong-evidence studies.
About This Consensus
This consensus synthesizes 416 peer-reviewed studies: 9 meta-analyses (2%), 99 observational studies (24%), 74 reviews (18%), 12 case studies (3%), 222 other study types (53%). Studies span from the earliest available research through 2025. Evidence strength ratings reflect study design, sample size, and replication across multiple research groups.
This page synthesizes findings from 416 peer-reviewed studies. It is not medical advice. Always consult a healthcare provider for personal health decisions.